STAT

AUGUST 13, 2024

WASHINGTON — The idea for Todd Wagner’s new advocacy organization FoodFight USA, he says, came to him after visiting George Clooney in Lake Como. He’s recruited Morgan Freeman, who is “obviously” a friend. He personally lobbied Arnold Schwarzenegger and current California Gov. Gavin Newsom to support food makers’ nightmare scenario — a first-in-the-nation law banning certain food additives in the state, which was signed into law last year.

363

363

PharmaVoice

AUGUST 13, 2024

A series of executive turnovers at Gain Therapeutics this year precedes important early-stage Parkinson’s results that could change how the disease is treated.

189

189

STAT

AUGUST 13, 2024

Cancer detection firm Grail announced sizable workforce cuts on Tuesday in a bid to save cash and concentrate resources on developing a blood-based test to spot early signs of dozens of cancers. The cuts will affect 30% of the biotech’s current and planned hires. Grail spokesperson Kristen Davis told STAT in an email that around 350 existing positions and 150 open roles have been eliminated.

357

357

PharmaVoice

AUGUST 13, 2024

Immunic’s treatment has anti-inflammation, neuroprotection and antiviral effects plus a ‘benign’ safety profile that even seems to lower the risk of COVID-19 infection.

Immunity 162

Immunity Immunization 162

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

AUGUST 13, 2024

SAN DIEGO — The unwinding of Illumina’s ill-fated acquisition of Grail earlier this year left investors and the genomics community with a pressing question: What kind of company is Illumina going to be going forward? CEO Jacob Thaysen on Tuesday made clear that the sequencing firm, which controls about 80% of the current DNA-sequencer market, is essentially returning to its traditional role of creating instruments for researchers in academia, the biopharma industry, and health care

344

344

pharmaphorum

AUGUST 13, 2024

Our longtime Finance Director Paul Bannister was a part of the fabric of pharmaphorum almost from the beginning and an integral part of keeping the publication running. And, most importantly, he was the soul of the place and a friend to all.

107

107

pharmaphorum

AUGUST 13, 2024

With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well as the need for correct education of people and machines, both.

114

114

STAT

AUGUST 13, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, the FDA’s recent rejection of an MDMA therapy hasn’t seemed to deter some other companies from moving ahead with psychedelics studies. We discuss that, and also some big policy developments that are coming this week.

Drug Pricing 344

Drug Pricing Drug Development 344

Express Pharma

AUGUST 13, 2024

Syngene International, a contract research, development, and manufacturing organisation (CRDMO), has achieved a silver rating in the EcoVadis sustainability index. This rating reflects the company’s commitment to Environmental, Social, and Governance (ESG) practices and places Syngene among the top 15 per cent of companies assessed worldwide in the past year.

105

105

STAT

AUGUST 13, 2024

There are few things more exciting for researchers than to mount and complete a clinical trial that could change the practice of medicine and save lives. That’s what we experienced when The New England Journal of Medicine published our findings in January 2023 that aspirin was as effective at preventing life-threatening blood clots after surgery as was a far more expensive and more painful injectable blood thinner.

Hospitals 319

Hospitals 319

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Express Pharma

AUGUST 13, 2024

In the last few years, global disruptions have opened new challenges and frontiers across industries. From manufacturing to the delivery of critical services, industries and governments swiftly developed or turned to new and sustainable strategies for growth. The healthcare and pharma sector, standing on the frontlines, witnessed the most upheaval and evolution, especially in vaccine development, cold chain, storage and last-mile delivery.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 105

STAT

AUGUST 13, 2024

Acelyrin, a California biotech focused on immunology and inflammatory disease, announced Tuesday that its experimental drug for a common skin disorder succeeded in a late-stage clinical trial. That’s the kind of news that’s usually accompanied by plans to apply for regulatory approval to market a new therapy. But the results didn’t show a clear edge over competing products on the market or in development.

Drug Development 335

Drug Development 335

Express Pharma

AUGUST 13, 2024

Atopic dermatitis (AD) is experiencing a transformative shift in treatment management with recent drug approvals that address critical unmet needs. The introduction of novel therapies, such as Dermavant’s VTAMA (tapinarof) (Japan) and Arcutis’s ZORYVE (roflumilast) (US), with innovative mechanisms of action, offers hope for improved patient outcomes.

Labelling 105

Labelling 105

STAT

AUGUST 13, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Hello and happy Tuesday, D.C. Diagnosis readers! I’m sad that the Olympics are already over, and it seems like the athletes receiving free health care must be too.

Drug Pricing 311

Drug Pricing 311

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

AUGUST 13, 2024

Learn how real-world evidence platforms use real-world data (RWD) to advance precision medicine, bridging the gap between clinical trials and real-world patient outcomes.

110

110

STAT

AUGUST 13, 2024

Otsuka Pharmaceutical has started selling Rejoyn, its Food and Drug Administration cleared prescription app that treats the symptoms of major depressive disorder. And it’s hitting the market at a low price that Otsuka hopes will entice many people to give it a try. Otsuka will make the 6-week treatment available to patients through a prescription from their existing provider or through the treatment’s website where they can connect with a clinician from Wheel Health who can prescri

319

319

Pharmafile

AUGUST 13, 2024

The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine for the first time in newly diagnosed patients with higher-risk myelodysplastic syndrome (MDS). The post China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome appeared first on Pharmafile.

98

98

STAT

AUGUST 13, 2024

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. We’ve got some nice awards news this morning. Yesterday, my colleague and friend Jason Mast won the the 2024 Evert Clark/Seth Payne Award , for his reporting at the intersection of medical science, business, and human lives. I asked Jason if there was a STAT story he was most proud of and he shared this heart-wrenching one from last summer when the first gene therapy was approved fo

Hospitals 272

Hospitals 272

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Compounding Pharmacy of America

AUGUST 13, 2024

Stuck in a weight loss plateau? Learn effective tips, strategies and supplements to help break through and continue your fitness journey. The post What Do You Do When You Hit a Weight Loss Plateau? appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 98

Compounding Pharmacies Compounding 98

Drug Channels

AUGUST 13, 2024

Last fall, poor ol’ Rite Aid finally succumbed to bankruptcy. It was pretty much the definition of an expected surprise. To get a comprehensive look at the company’s ever-declining fortunes, DCI rummaged around the compnay's numerous bankruptcy filings. Below, you’ll find our review of Rite Aid’s current financial situation, shrinking store footprint, changing relationship with key wholesaler McKesson, surprisingly optimistic projections, and more.

91

91

Outsourcing Pharma

AUGUST 13, 2024

Driven by personal loss and inspired by the progress in disease management, Elaine has dedicated more than 20 years to the clinical trial technology industry.

95

95

Pharmaceutical Technology

AUGUST 13, 2024

Ascendis Pharma has obtained US Food and Drug Administration (FDA) approval for its YORVIPATH to treat hypoparathyroidism in adults.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

AUGUST 13, 2024

In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring quality, efficiency, and innovation.

92

92

Pharma Times

AUGUST 13, 2024

The rare, peripheral neuropathy disease affects nearly three million people globally

Hospitals 108

Hospitals 108

Outsourcing Pharma

AUGUST 13, 2024

Patients suffering from severe allergic reactions now have access to a new, needle-free treatment option, as the US Food and Drug Administration (FDA) has approved neffy, a 2 mg epinephrine nasal spray developed by ARS Pharmaceuticals, Inc.

78

78

PioneerRx

AUGUST 13, 2024

The back-to-school rush is in full swing. Vacations now have to wait for cozy autumns and icy winters to happen. Once class is in session, however, the rush.

81

81

Pharma Times

AUGUST 13, 2024

The V-ATPase protein, V1H, was found to be involved in the process of raising the alarm

103

103

BioPharma Dive

AUGUST 13, 2024

The company will no longer develop its medicine izokibep in two immune conditions, prioritizing instead another treatment it’s developing for thyroid eye disease.

Immunity 73

Immunity Immunization 73

pharmaphorum

AUGUST 13, 2024

Novartis' attempt to stop MSN Pharma from launching a generic version of heart failure blockbuster Entresto is blocked in a US court

99

99

Express Pharma

AUGUST 13, 2024

How can the pharma sector make sustainability more sustainable? Sustainability in the pharmaceutical sector is becoming increasingly critical. With growing awareness of the environmental impact of pharmaceutical manufacturing—such as pollution from toxic discharges—companies must adopt more sustainable practices. The industry is heavily regulated, which often makes the implementation of sustainable initiatives challenging and expensive.

Pharmaceutical Manufacturing 64

Pharmaceutical Manufacturing Packaging Biosimilars Pharmaceutical Companies 64

BioPharma Dive

AUGUST 13, 2024

Nemluvio is now cleared for adults with the chronic itching condition prurigo nodularis, making it a competitor to Sanofi and Regeneron’s Dupixent.

70

70

pharmaphorum

AUGUST 13, 2024

After turning it down a year ago, the FDA has cleared once-daily injectable Yorvipath for hypoparathyroidism from Ascendis Pharma.Yorvipath (palopegteriparatide) – previously known as TransCon PTH – has been approved to treat adults with hypoparathyroidism, a rare condition defined by a deficiency of parathyroid hormone (PTH) that affects 70,000 to 90,000 people in the US.

60

60